Challenge of developing new tuberculosis vaccines to generate life-long protective immunity

Expert Review of Vaccines

Volumn 8, Issue 7, 2009, Pages 823-825

  Triccas, James A ^a   Nambiar, Jonathan K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MVA 85A; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BCG VACCINATION; CLINICAL TRIAL; DRUG CLEARANCE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EDITORIAL; HUMAN; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

HUMANS; IMMUNOLOGIC MEMORY; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 67650456776     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.09.50     Document Type: Editorial

References (22)

1. Verver S, Warren RM, Beyers N et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care. Med. 171, 1430-1435 (2005). (Pubitemid 40800517)
2. Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17, 326-332 (2005). (Pubitemid 40692670)
3. Ryan AA, Nambiar JK, Wozniak TM et al. Antigen load governs the differential priming of CD8 T cells in response to the BCG vaccine or Mycobacterium tuberculosis infection. J. Immunol. 182, 7172-7177 (2009).
4. Billeskov R, Vingsbo-Lundberg C, Andersen P, Dietrich J. Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J. Immunol. 179, 3973-3981 (2007).
5. Fine PE. BCG: the challenge continues. Scand. J. Infect. Dis. 33, 243-245 (2001).
6. Mollenkopf HJ, Kursar M, Kaufmann SH. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Mycobacterium bovis bacille Calmette-Guérin induce equal protection. J. Infect. Dis. 190, 588-597 (2004). (Pubitemid 38982100)
7. Pinto R, Saunders BM, Camacho LR, Britton WJ, Gicquel B, Triccas JA. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine. J. Infect. Dis. 189, 105-112 (2004). (Pubitemid 38122336)
8. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung. Dis. 2, 2000-2007 (1998).
9. Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348, 17-24 (1996).
10. McShane H, Pathan AA, Sander CR et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10, 1240-1244 (2004). (Pubitemid 39540442)
11. Hoft DF. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 372, 164-175 (2008). (Pubitemid 351952260)
12. Ramirez JC, Gherardi MM, Esteban M. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J. Virol. 74, 923-933 (2000). (Pubitemid 30036229)
13. Halbert CL, Miller AD. AAV-mediated gene transfer to mouse lungs. Methods Mol. Biol. 246, 201-212 (2004).
14. Ryan AA, Wozniak TM, Shklovskaya E et al. Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guérin secreting murine GM-CSF is associated with expansion and activation of APCs. J. Immunol. 179, 8418-8424 (2007).
15. Tang C, Yamada H, Shibata K et al. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/ antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. J. Infect. Dis. 197, 1263-1274 (2008). (Pubitemid 351632757)
16. Grode L, Seiler P, Baumann S et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J. Clin. Invest. 115, 2472-2479 (2005). (Pubitemid 41266209)
17. Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, Eissa NT. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat. Med. 15, 267-276 (2009).
18. +IL-7Rhi T cells. Eur. J. Immunol. 38, 30-39 (2008).
19. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46, 709-717 (2002). (Pubitemid 35365606)
20. Pym AS, Brodin P, Majlessi L et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9, 533-539 (2003). (Pubitemid 36597098)
21. Gonzalo-Asensio J, Mostowy S, Harders-Westerveen J et al. PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS ONE 3, e3496 (2008).
22. Clinical Trials www.clinicaltrials.gov